These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 5529668)

  • 21. [Therapeutic effects of Reparil. Clinical experimental studies and therapeutic observations].
    Steinacher J
    Z Haut Geschlechtskr; 1972 Jul; 47(13):559-64. PubMed ID: 4569258
    [No Abstract]   [Full Text] [Related]  

  • 22. [Participation of a new cerebral vasodilator, 1,035 M.D. in the involutional psychoses of chronic alcoholism].
    Ducamin JP; Cron
    Encephale; 1969; 58(3):283-7. PubMed ID: 5378186
    [No Abstract]   [Full Text] [Related]  

  • 23. [The possibilities and limitations of psychotropic drug therapy for patients with glaucoma].
    Gol'dovskaia IL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(9):1402-5. PubMed ID: 4417274
    [No Abstract]   [Full Text] [Related]  

  • 24. [Experimental studies on the effectiveness of aescin "Reparil" in Parkinson patients].
    Tzavellas O
    Wien Klin Wochenschr; 1968 Jan; 80(2):30-4. PubMed ID: 5691318
    [No Abstract]   [Full Text] [Related]  

  • 25. [Wallerox increases cerebral circulation and heart capacity].
    Heynen U
    Z Allgemeinmed; 1971 Dec; 47(34):1823-5. PubMed ID: 5003212
    [No Abstract]   [Full Text] [Related]  

  • 26. A double-blind trial of the efficacy of promazine in the treatment of alcohol withdrawal syndrome.
    Schwarz L; Schmidt H; Stern JA
    Dis Nerv Syst; 1968 Mar; 29(3):173-7. PubMed ID: 4877336
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical experience with the new phenothiazine derivative chlorimpiphenine].
    Reimer F; Christiani K
    Med Klin; 1967 Sep; 62(39):1515-6. PubMed ID: 5596491
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of mental manifestations of chronic cerebral circulatory insufficiency. Clinical and psychometric study].
    Lefebvre P; Crocq L; Bernard JG
    Sem Hop; 1969 Jan; 45(5):312-7. PubMed ID: 4307724
    [No Abstract]   [Full Text] [Related]  

  • 29. Papaverin in the treatment of geriatric patients.
    Bambasová E; Bílková J; Budínská K
    Act Nerv Super (Praha); 1974 Aug; 16(3):191-2. PubMed ID: 4609360
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical, rheoencephalographic and ophthalmodynamographic double-blind studies of the effects of vincamine in the treatment of cerebrovascular diseases].
    Kauchtschischvili G; Nappi G; Bono G
    Minerva Med; 1974 May; 65(40):2296-315. PubMed ID: 4608671
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical experience with treatment by piracetam in gerontopsychiatry (author's transl)].
    Vencovský E; Hronek J; Drahokoupil L; Fait V; Hudcová T; Laciga Z; Vanková H
    Cesk Psychiatr; 1980 Apr; 76(2):89-97. PubMed ID: 6994907
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug treatment of the alcohol withdrawal syndrome and delirium tremens. A comparison of haloperidol with mesoridazine and hydroxyzine.
    Palestine ML
    Q J Stud Alcohol; 1973 Mar; 34(1):185-93. PubMed ID: 4572441
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical and experimental experience with the nicotinic acid ester 7-oxyethyltheophylline].
    Fischbach R; Haas R
    Arzneimittelforschung; 1967 Mar; 17(3):313-7. PubMed ID: 5631222
    [No Abstract]   [Full Text] [Related]  

  • 34. [On the diagnostic importance of studying the vascular system of the eye in mental disorders of old age].
    Gol'dovskaia IL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(12):1831-6. PubMed ID: 5601843
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of Cinnarizine in cerebral arteriosclerosis. Improvement of the clinical picture as a result of increased oxygen supply and utilization due to Cinnarizine].
    Reimann-Hunziker R; Reimann-Hunziker GJ
    Praxis; 1969 Sep; 58(39):1239-42. PubMed ID: 4899503
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of luliberin in the treatment of mental disorders in cerebral arteriosclerosis].
    Tikhomirov SM; Bakharev VM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(1):121-3. PubMed ID: 2158710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical studies with oxypertine in chronically psychotic patients].
    Eckmann F; Badalik L
    Arzneimittelforschung; 1970 Feb; 20(2):268-9. PubMed ID: 5467473
    [No Abstract]   [Full Text] [Related]  

  • 38. [Double blind study as evidence of the therapeutic effect of Melissengeist on psycho-vegetative syndromes (author's transl)].
    Büchner KH; Hellings H; Huber M; Peukert E; Späth L; Deininger R
    Med Klin; 1974 Jun; 69(23):1032-6. PubMed ID: 4603097
    [No Abstract]   [Full Text] [Related]  

  • 39. An evaluation of the permanence of the "tardive dyskinesias".
    Paulson GW
    Dis Nerv Syst; 1968 Oct; 29(10):692-4. PubMed ID: 5717285
    [No Abstract]   [Full Text] [Related]  

  • 40. [Drug therapy in cerebral disorders. A double-blind study with Cetal retard in aged subjects].
    Schenker H
    Med Klin; 1979 Oct; Suppl():48-50. PubMed ID: 542168
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.